These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 15908606

  • 1. Tripeptidyl peptidase II. An oligomeric protease complex from Arabidopsis.
    Book AJ, Yang P, Scalf M, Smith LM, Vierstra RD.
    Plant Physiol; 2005 Jun; 138(2):1046-57. PubMed ID: 15908606
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In situ structural studies of tripeptidyl peptidase II (TPPII) reveal spatial association with proteasomes.
    Fukuda Y, Beck F, Plitzko JM, Baumeister W.
    Proc Natl Acad Sci U S A; 2017 Apr 25; 114(17):4412-4417. PubMed ID: 28396430
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tripeptidyl-peptidase II: a multi-purpose peptidase.
    Tomkinson B, Lindås AC.
    Int J Biochem Cell Biol; 2005 Oct 25; 37(10):1933-7. PubMed ID: 16125107
    [Abstract] [Full Text] [Related]

  • 7. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.
    Reits E, Neijssen J, Herberts C, Benckhuijsen W, Janssen L, Drijfhout JW, Neefjes J.
    Immunity; 2004 Apr 25; 20(4):495-506. PubMed ID: 15084277
    [Abstract] [Full Text] [Related]

  • 8. Molecular architecture and assembly mechanism of Drosophila tripeptidyl peptidase II.
    Rockel B, Peters J, Müller SA, Seyit G, Ringler P, Hegerl R, Glaeser RM, Baumeister W.
    Proc Natl Acad Sci U S A; 2005 Jul 19; 102(29):10135-40. PubMed ID: 16006508
    [Abstract] [Full Text] [Related]

  • 9. Effect of cancer cachexia on the activity of tripeptidyl-peptidase II in skeletal muscle.
    Chand A, Wyke SM, Tisdale MJ.
    Cancer Lett; 2005 Feb 10; 218(2):215-22. PubMed ID: 15670899
    [Abstract] [Full Text] [Related]

  • 10. Characterization and inhibition of a cholecystokinin-inactivating serine peptidase.
    Rose C, Vargas F, Facchinetti P, Bourgeat P, Bambal RB, Bishop PB, Chan SM, Moore AN, Ganellin CR, Schwartz JC.
    Nature; 1996 Apr 04; 380(6573):403-9. PubMed ID: 8602240
    [Abstract] [Full Text] [Related]

  • 11. Structure and function of tripeptidyl peptidase II, a giant cytosolic protease.
    Rockel B, Kopec KO, Lupas AN, Baumeister W.
    Biochim Biophys Acta; 2012 Jan 04; 1824(1):237-45. PubMed ID: 21771670
    [Abstract] [Full Text] [Related]

  • 12. Exploring the active site of tripeptidyl-peptidase II through studies of pH dependence of reaction kinetics.
    Eklund S, Lindås AC, Hamnevik E, Widersten M, Tomkinson B.
    Biochim Biophys Acta; 2012 Apr 04; 1824(4):561-70. PubMed ID: 22266401
    [Abstract] [Full Text] [Related]

  • 13. Tripeptidyl peptidase II promotes fat formation in a conserved fashion.
    McKay RM, McKay JP, Suh JM, Avery L, Graff JM.
    EMBO Rep; 2007 Dec 04; 8(12):1183-9. PubMed ID: 17932511
    [Abstract] [Full Text] [Related]

  • 14. Inhibitor-based validation of a homology model of the active-site of tripeptidyl peptidase II.
    De Winter H, Breslin H, Miskowski T, Kavash R, Somers M.
    J Mol Graph Model; 2005 Apr 04; 23(5):409-18. PubMed ID: 15781183
    [Abstract] [Full Text] [Related]

  • 15. Role of tripeptidyl peptidase II in MHC class I antigen presentation: Biological characteristics, cellular crosstalk and signaling.
    Tan Q, Ma S, Hu J, Chen X, Yu Y, Zang G, Tang Z.
    Biomed Pharmacother; 2016 Dec 04; 84():1954-1958. PubMed ID: 27829551
    [Abstract] [Full Text] [Related]

  • 16. Evidence for the Existence in Arabidopsis thaliana of the Proteasome Proteolytic Pathway: ACTIVATION IN RESPONSE TO CADMIUM.
    Polge C, Jaquinod M, Holzer F, Bourguignon J, Walling L, Brouquisse R.
    J Biol Chem; 2009 Dec 18; 284(51):35412-24. PubMed ID: 19822524
    [Abstract] [Full Text] [Related]

  • 17. No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes.
    Basler M, Groettrup M.
    Eur J Immunol; 2007 Apr 18; 37(4):896-904. PubMed ID: 17357105
    [Abstract] [Full Text] [Related]

  • 18. The structure of human tripeptidyl peptidase II as determined by a hybrid approach.
    Schönegge AM, Villa E, Förster F, Hegerl R, Peters J, Baumeister W, Rockel B.
    Structure; 2012 Apr 04; 20(4):593-603. PubMed ID: 22483107
    [Abstract] [Full Text] [Related]

  • 19. Effects of an inhibitor of tripeptidyl peptidase II (Ala-Ala-Phe-chloromethylketone) and its combination with an inhibitor of the chymotrypsin-like activity of the proteasome (PSI) on apoptosis, cell cycle and proteasome activity in U937 cells.
    Bury M, Młynarczuk I, Pleban E, Hoser G, Kawiak J, Wójcik C.
    Folia Histochem Cytobiol; 2001 Apr 04; 39(2):131-2. PubMed ID: 11374791
    [Abstract] [Full Text] [Related]

  • 20. Accumulation of polyubiquitylated proteins in response to Ala-Ala-Phe-chloromethylketone is independent of the inhibition of Tripeptidyl peptidase II.
    Villasevil EM, Guil S, López-Ferreras L, Sánchez C, Del Val M, Antón LC.
    Biochim Biophys Acta; 2010 Sep 04; 1803(9):1094-105. PubMed ID: 20553980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.